Toxoplasma gondii impairs CX3CL1/fractalkine shedding from mouse cortical neurons, leading to microglia activation
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.01074-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Leonardo Leal de Castro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Chemokine CX3CL1, Neurons, Toxoplasma, Microglia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, Fundação Oswaldo Cruz.
Abstract (Originalsprache)
Toxoplasmosis is caused by infection with Toxoplasma gondii and is one of the most prevalent food-borne parasitic disease worldwide. T. gondii disseminates through the host organism and forms a latency-specific structure called bradyzoite cysts, found primarily in muscle and neuronal cells. In mice, Toxoplasma leads to sustained brain microvascular abnormalities, including capillary rarefaction, microglial activation, and blood-brain barrier (BBB) breakdown, resulting in synaptic and neuronal loss, behavioral and cognitive damages. We hypothesized that cyst-bearing neurons could signal distinct classes of molecules that would orchestrate neurovascular and neuroinflammatory processes. Primary mouse cortical neurons were infected with T. gondii (ME49 strain) tachyzoites, which, 7 days post infection, generated cysts. We determined angiogenic-regulating factors from the neuronal conditioned media (nCM) using a proteome array and found nine molecules, belonging to four main functional clusters: (i) angiogenic signaling (VEGFA); (ii) endothelial-regulating growth factors (IGFBP-2, -3, -9 and PDGF-AA), (iii) chemoattractants (CCL-2, CCL-3, and CXCL12), and (iv) fractalkine signaling (CX3CL1). The main targets were validated in neuronal culture samples and in brain cortices by ELISA, RT-qPCR, or immunoblotting. CX3CL1 secretion was reduced in infected cultures and accumulated on neuronal surface. In vivo , the CX3CL1 receptor (CX3CR1) was upregulated, whereas the CX3CL1 soluble fraction was decreased. Recombinant CX3CL1 decreased arginase-1 and increased iNOS expression in nCM-treated microglial cells, indicating that CX3CL1 polarizes microglia to a pro-resolutive state. Our data suggest that CX3CL1 plays a key role in regulating neuroinflammatory signaling in acquired Toxoplasmosis, highlighting its potential to prevent the neurocognitive damage observed in infected individuals. IMPORTANCE Toxoplasma gondii is a widespread parasite that forms latent cysts in neurons during chronic brain infection. How these infected neurons contribute to long-term brain damage is not well understood. In this study, we used a neuron-specific culture system and a mouse model to show that T. gondii infection alters the release of key signaling molecules by neurons. We found that infected neurons reduce secretion of fractalkine, a molecule that normally helps keep brain immune cells (microglia) in a resting state. At the same time, infected neurons showed increased expression of inflammatory and vascular-related genes, but not always matching increases in protein levels, pointing to complex regulation. These changes may contribute to blood-brain barrier dysfunction and persistent inflammation seen in chronic infection. Our findings highlight the role of neuron-derived signals in driving T. gondii -induced brain pathology and identify fractalkine as a potential target to reduce inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
- Laboratório de Imunologia Molecular e Celular, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
- Laboratory of Ocular Immunology and Transplantation, Bascom Palmer Eye Institute, University of Miami, Miami, Florida, USA.
- Laboratório de Inovações em Terapias, Ensino e Bioprodutos, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
- Laboratório de Investigação Metabólica Associada ao Envelhecimento, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
- Department of Biology, University of Miami, Miami, Florida, USA.
ORCID-Profile: Daniel Adesse
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- Fundação Oswaldo Cruz
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
de Castro, L. L., Gomes da Rosa, B., Peixoto-Rodrigues, M. C., Revoredo Vicentino, A. R., Fraga-Junior, V. S., Cascabulho, C. M., Diniz, L. P., Benjamim, C. F., Bracko, O., Scharfstein, J., & Adesse, D. (2025). Toxoplasma gondii impairs CX3CL1/fractalkine shedding from mouse cortical neurons, leading to microglia activation. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01074-25
Vancouver
de Castro LL, Gomes da Rosa B, Peixoto-Rodrigues MC, Revoredo Vicentino AR, Fraga-Junior VS, Cascabulho CM, et al. Toxoplasma gondii impairs CX3CL1/fractalkine shedding from mouse cortical neurons, leading to microglia activation. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01074-25
BibTeX
@article{deCastro2025,
author = {de Castro, Leonardo Leal and Gomes da Rosa, Barbara and Peixoto-Rodrigues, Maria Carolina and Revoredo Vicentino, Amanda Roberta and Fraga-Junior, Vanderlei da Silva and Cascabulho, Cynthia M and Diniz, Luan Pereira and Benjamim, Claudia Farias and Bracko, Oliver and Scharfstein, Julio and Adesse, Daniel},
title = {Toxoplasma gondii impairs CX3CL1/fractalkine shedding from mouse cortical neurons, leading to microglia activation},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.01074-25}
}
EUVIMED